Maxwell® CSC Viral Total Nucleic Acid Purification Kit Technical Manual
Instructions for Use of Product(s)
AS1780
Literature # TM624
The Maxwell® CSC Viral Total Nucleic Acid Purification Kit is used with the Maxwell® CSC Instruments to provide an easy method for efficient, automated sample preparation and purification of viral total nucleic acid. Maxwell® CSC Instruments are designed for use with predispensed reagent cartridges and preprogrammed purification procedures, maximizing simplicity and convenience. The Maxwell® method for the CSC Viral Total Nucleic Acid Kit can process from one to 16 samples using the Maxwell® CSC Instrument (Cat.# AS6000) or one to 48 samples using the Maxwell® CSC 48 Instrument (Cat.# AS8000) in approximately 30 minutes. The low elution volume of 50μl results in concentrated purified nucleic acid for downstream applications such as quantitative PCR (qPCR) or quantitative RT-PCR (qRT-PCR). After brief initial lysis, the sample is added to the Maxwell® CSC Viral Total Nucleic Acid Purification Cartridge, and the remaining processing is fully automated.
The Maxwell® CSC Viral Total Nucleic Acid Purification Kit is intended for use, in combination with Maxwell® CSC Instruments and the Maxwell® CSC Viral Total Nucleic Acid purification method, as an in vitro diagnostic (IVD) medical device to perform automated isolation of total viral nucleic acid from human samples. The purified nucleic acid is suitable for use in amplification-based in vitro diagnostic assays. The Maxwell® CSC Viral Total Nucleic Acid Purification Kit is intended for professional use only. Diagnostic results obtained using the nucleic acid purified with this system must be interpreted in conjunction with other clinical or laboratory data.
For In Vitro Diagnostic Use. Professional use only.
The Maxwell® CSC Viral Total Nucleic Acid Purification Kit is only available in Austria, Belgium, Canada, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Singapore, Slovakia, Slovenia, Spain, Sweden, Switzerland and United Kingdom, Korea and the United States.
Summary of Changes
See the Technical Manual for a Summary of Changes.
Revised 5/21 (Korea). Revised 10/22 (other locations).
